C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2007
10/17/2007	EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007	EP1144006B1 CCR5 Antibody PA14
10/17/2007	CN101056987A Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes
10/17/2007	CN101056979A Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same
10/17/2007	CN101054598A Method for preparing cotton dreg peptide protein by organism ferment
10/17/2007	CN101054592A Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system
10/17/2007	CN101054588A Mutant aprE promoter
10/17/2007	CN101054569A Gene engineering bacterium, preparation and use thereof
10/17/2007	CN101054560A Biosynthesis method for glutathione by enzyme engineering technique
10/17/2007	CN101054417A Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
10/17/2007	CN100343392C Process for producing soybean protein peptide using soybean as raw material
10/17/2007	CN100343282C Hybrid interferon compositions and methods of use
10/16/2007	US7282579 Serine protease BSSP6
10/16/2007	US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings
10/16/2007	US7282572 Method and device for improving protein stability and solubility
10/16/2007	US7282570 Nucleotide sequences for use in the treatment and diagnosis of immunological and inflammatory disorders
10/16/2007	US7282569 PRO1508 antibodies
10/16/2007	US7282564 RNA interference pathway genes as tools for targeted genetic interference
10/16/2007	US7282562 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
10/16/2007	US7282561 PRO16090 polypeptides
10/16/2007	US7282560 PRO 4326 polypeptides
10/16/2007	US7282559 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2007	US7282558 PRO4329 polypeptide
10/16/2007	US7282557 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
10/16/2007	US7282490 Osteopontin-related compositions and methods
10/16/2007	US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia
10/16/2007	US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity
10/16/2007	US7282357 Method for the production by fermentation of sulphur-containing fine chemicals (metF)
10/16/2007	US7282354 Method for producing fermented milk product
10/16/2007	US7282353 Protein isolation
10/16/2007	US7282352 Substituting the endogenous signal peptide of a subunit of FSH with an amino acid sequence comprising the signal peptide of human growth hormone (hGH).
10/16/2007	US7282351 Prostatic growth factor
10/16/2007	US7282346 Monitoring and classifying the spread of cancer in humans; obtain biopsy of tissue, determine concentration of tumor suppressor protein, determine thrombospondin concentration, monitor vascularization, evaluate cell for tumor propagation
10/16/2007	US7282341 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time
10/16/2007	US7282326 Recombinational cloning using engineered recombination sites
10/16/2007	US7282210 Process for the in vitro culture of different stages of tissular parasites
10/16/2007	US7282205 Anti-hepatitis A virus antibodies
10/16/2007	US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders
10/16/2007	US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
10/16/2007	CA2326413C Process for enriching for helicobacter pylori neutrophil activating protein (nap)
10/16/2007	CA2157375C Extraction of cell-bound protein from bordetella
10/16/2007	CA2155793C Monoclonal antibiodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids
10/16/2007	CA2124126C Monoclonal antibodies and fv specific for cd2 antigen
10/16/2007	CA2094243C Streptolysin o variants
10/14/2007	CA2584894A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
10/11/2007	WO2007114496A1 Novel anti-cd98 antibody
10/11/2007	WO2007114337A1 Immune agglutination reaction reagent kit and method of assaying antigen
10/11/2007	WO2007114325A1 Antibody modification method for purifying bispecific antibody
10/11/2007	WO2007114319A1 Method for control of blood kinetics of antibody
10/11/2007	WO2007114307A1 Mucin-type glycopeptide having polylactosamine backbone
10/11/2007	WO2007114214A1 CRYSTAL OF PENICILLIN-BINDING PROTEIN (PBP) 2b
10/11/2007	WO2007112677A1 Method of preparing human parathyroid hormone 1-34
10/11/2007	WO2006096392A3 Enzymes involved in astaxanthin, carotenoid and isoprenoid biosynthetic pathways, genes encoding them and methods of making and using them
10/11/2007	WO2005115394A3 Prenyl-electrostatic switch, and methods of use
10/11/2007	WO2004007527A3 Secreted proteins
10/11/2007	US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis
10/11/2007	US20070238859 Wound healing agents; anticancer agents; cardiovascular disorders
10/11/2007	US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells
10/11/2007	US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007	US20070238664 70 Human Secreted Proteins
10/11/2007	US20070238658 IL-17A and IL-17F Antagonists and Methods of Using the Same
10/11/2007	US20070238651 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha1-2fucosyltransferase and uses thereof
10/11/2007	US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007	US20070238194 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver and uses thereof
10/11/2007	US20070238154 Humanized antibodies that recognize beta-amyloid peptide
10/11/2007	US20070238153 Processes for improved disulfide bond formation in recombinant systems
10/11/2007	US20070238152 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
10/11/2007	US20070238151 Novel compounds
10/11/2007	US20070238150 Pro4356 polypeptides
10/11/2007	US20070238149 nucleotide sequences that code for polypeptides having oxidoreductase enzyme activity useful for biosynthesis of astaxanthin
10/11/2007	US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007	US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007	US20070238134 Cell cycle proteins associated with rad9, compositions and methods of use
10/11/2007	US20070238097 Method used to survey for presence of avian antibodies which reflect exposure to an immunogen
10/11/2007	US20070237794 Compounds and Methods for Diagnosis and Treatment of Leishmaniasis
10/11/2007	US20070237793 Attenuated or mutated pasteurella for use as tool in developing bactericidal agents; immunotherapy; immunogens for vaccines
10/11/2007	US20070237776 Binds to hIL-18R alpha with high affinity and by the ability to neutralize hIL-18 activity, including IL-18-induced interferon gamma expression and IL-18-induced cellular activation; sepsis; cardiovascular disorders; liver injury; arthritis, including rheumatoid arthritis; inflammatory bowel diseases
10/11/2007	US20070237759 Antibodies that bind PAR-2
10/11/2007	US20070237745 SISP-1 (Stress induced Secreted Protein 1); induces apoptosis by interaction with p53; treating abnormal apoptosis such as tumor
10/11/2007	CA2648618A1 Novel anti-cd98 antibody
10/11/2007	CA2647846A1 Method for control of blood kinetics of antibody
10/10/2007	EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007	EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007	EP1842912A1 Method of breeding cells having improved tolerance to short-chain fatty acids
10/10/2007	EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007	EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007	EP1842548A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug
10/10/2007	EP1601450A4 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
10/10/2007	EP1380653B1 Method of assaying lupus anticoagulant and assay reagent
10/10/2007	EP1177301B1 Chlamydia antigens and corresponding dna fragments and uses thereof
10/10/2007	EP1068241B1 Antibody variants and fragments thereof
10/10/2007	EP0978565B1 Process for producing peptide with the use of accessory peptide
10/10/2007	EP0870014B9 Aldolase catalytic antibody
10/10/2007	CN101052726A IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/10/2007	CN101052725A T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
10/10/2007	CN101052715A Catalyst
10/10/2007	CN101052713A Single protein production in living cells facilitated by a messenger RNA interferase
10/10/2007	CN101052417A Prevention and treatment of synucleinopathic and amyloidogenic disease
10/10/2007	CN101050464A Method for preparing A gene of recombined protein, and expressed products and application
10/10/2007	CN101050437A Method for producing bacterial strain of Pediococcus acidilactici, and bacterin of Pediococcus acidilactici

1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 1125